Sutro Biopharma, Inc.
STRO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$227 | -$107 | -$119 | -$106 |
| Dep. & Amort. | $7 | $7 | $6 | $5 |
| Deferred Tax | $0 | $0 | $0 | $7 |
| Stock-Based Comp. | $25 | $25 | $26 | $23 |
| Change in WC | $9 | -$34 | $104 | -$18 |
| Other Non-Cash | -$5 | -$2 | -$14 | $6 |
| Operating Cash Flow | -$192 | -$112 | $4 | -$82 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3 | -$4 | -$8 | -$15 |
| Net Acquisitions | $0 | $0 | $29 | $0 |
| Inv. Purchases | -$462 | -$460 | -$217 | -$249 |
| Inv. Sales/Matur. | $683 | $461 | $189 | $167 |
| Other Inv. Act. | $0 | $0 | -$29 | $0 |
| Investing Cash Flow | $219 | -$4 | -$35 | -$97 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$4 | -$13 | -$9 | $0 |
| Stock Issued | $97 | $12 | $56 | $0 |
| Stock Repurch. | $0 | $0 | $0 | -$0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2 | $138 | $1 | $3 |
| Financing Cash Flow | $94 | $138 | $48 | $3 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $121 | $22 | $17 | -$176 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $70 | $48 | $31 | $207 |
| End Cash | $191 | $70 | $48 | $31 |
| Free Cash Flow | -$195 | -$116 | -$4 | -$97 |